Phosphatase SHP-1 promotes TLR-and RIG-I-activated production of type I interferon by inhibiting the kinase IRAK1

H An, J Hou, J Zhou, W Zhao, H Xu, Y Zheng, Y Yu… - Nature …, 2008 - nature.com
H An, J Hou, J Zhou, W Zhao, H Xu, Y Zheng, Y Yu, S Liu, X Cao
Nature immunology, 2008nature.com
Unbalanced production of proinflammatory cytokines and type I interferons in immune
responses may lead to immunopathology; thus, the mechanisms that ensure the beneficial
production of proinflammatory cytokines and type I interferons are of particular importance.
Here we demonstrate that the phosphatase SHP-1 negatively regulated Toll-like receptor–
mediated production of proinflammatory cytokines by inhibiting activation of the transcription
factor NF-κB and mitogen-activated protein kinase. Simultaneously, SHP-1 increased the …
Abstract
Unbalanced production of proinflammatory cytokines and type I interferons in immune responses may lead to immunopathology; thus, the mechanisms that ensure the beneficial production of proinflammatory cytokines and type I interferons are of particular importance. Here we demonstrate that the phosphatase SHP-1 negatively regulated Toll-like receptor–mediated production of proinflammatory cytokines by inhibiting activation of the transcription factor NF-κB and mitogen-activated protein kinase. Simultaneously, SHP-1 increased the production of type I interferon mediated by Toll-like receptors and the helicase RIG-I by directly binding to and inhibiting activation of the kinase IRAK1. Our data demonstrate that SHP-1 contributes to immune homeostasis by balancing the production of proinflammatory cytokines and type I interferons in the innate immune response.
nature.com